Edition:
United States

C-Rad AB (CRADb.ST)

CRADb.ST on Stockholm Stock Exchange

31.00SEK
11:29am EDT
Change (% chg)

1.60kr (+5.44%)
Prev Close
29.40kr
Open
29.10kr
Day's High
31.00kr
Day's Low
29.10kr
Volume
440,791
Avg. Vol
130,632
52-wk High
31.00kr
52-wk Low
9.85kr

CRADb.ST

Chart for CRADb.ST

About

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning,... (more)
No analyst recommendations are available for CRADb.ST.

Overall

Beta: 0.85
Market Cap(Mil.): kr842.86
Shares Outstanding(Mil.): 28.67
Dividend: --
Yield (%): --

Financials

  CRADb.ST Industry Sector
P/E (TTM): -- 118.24 32.70
EPS (TTM): -0.79 -- --
ROI: -30.68 9.40 14.88
ROE: -36.93 14.58 16.12

BRIEF-C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna

* C-RAD TO SUPPLY ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA

Aug 03 2017

BRIEF-C-Rad to provide solutions to University Medical Center Freiburg

* UNIVERSITY MEDICAL CENTER FREIBURG, GERMANY DECIDES FOR C-RAD’S INNOVATIVE SIGRT SOLUTION

Jul 21 2017

BRIEF-C-Rad receives an order from two cancer centres in France

* CANCER CENTERS IN FRANCE DECIDE FOR C-RAD’S INNOVATIVE SIGRT SOLUTION

Jun 28 2017

BRIEF-C-Rad: ‍Patent and Market appeal court confirms right to invention ​

* ‍PATENT AND MARKET APPEAL COURT CONFIRMED IN ITS JUDGMENT C-RAD'S RIGHT TO INVENTION NAMED "PATIENT MONITORING RADIATION MACHINES"​

Jun 20 2017

BRIEF-C-Rad files a patent entitlement law suit against Beamocular

* C-RAD FILES A PATENT ENTITLEMENT LAW SUIT AGAINST BEAMOCULAR

May 24 2017

BRIEF-C-Rad Q1 net sales rise to SEK 25.8 million

* Q1 NET SALES SEK 25.8 MILLION VERSUS SEK 17.3 MILLION YEAR AGO

Apr 28 2017

BRIEF-C-RAD sells SIGRT solution to Miami Cancer Institute

* MIAMI CANCER INSTITUTE DECIDES FOR C-RAD'S SIGRT SOLUTION FOR THEIR NEW PROTON CENTER IN MIAMI, FLORIDA

Apr 18 2017

Earnings vs. Estimates